Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease

被引:5
|
作者
King, Annesha C. [1 ,2 ]
Wood, Tara E. [2 ]
Rodriguez, Efrain [2 ]
Parpura, Vladimir [3 ]
Gray, Michelle [2 ,3 ]
机构
[1] Univ Alabama Birmingham, Grad Biomed Sci Neurosci Theme, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
Huntington's disease; Full-length mutant huntingtin; Huntingtin; Astrocytes; Gliotransmission; BACHD; dnSNARE; MUTANT HUNTINGTIN; GLUTAMATE TRANSPORT; SECRETORY-CELLS; SEX-DIFFERENCES; IN-VIVO; ASTROCYTES; EXPRESSION; RELEASE; SYMPTOMS; R6/2;
D O I
10.1016/j.expneurol.2020.113358
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by a polyglutamine expansion in the widely expressed huntingtin protein. Multiple studies have indicated the importance of mutant huntingtin (mHTT) in astrocytes to HD pathogenesis. Astrocytes exhibit SNARE-dependent exocytosis and gliotransmission, which can be hampered by transgenic expression of dominant negative SNARE (dnSNARE) in these glial cells. We used BACHD mice and crossed them with the dnSNARE model to determine if pan-astrocytic SNARE-dependent exocytosis plays an important role in vivo in the progression of HD behavioral phenotypes. We assessed motor and neuropsychiatric behaviors in these mice. At 12 months of age there was a significant improvement in motor coordination (rotarod test) in BACHD/dnSNARE mice when compared to BACHD mice. Analyses of open field performance revealed significant worsening of center entry (at 9 and 12 months), but not distance traveled in BACHD/dnSNARE when compared to BACHD mice, and variable/inconclusive results on vertical plane entry. While no differences between BACHD and BACHD/dnSNARE mice at 12 months of age in the forced swim test were found, we did observe a significant decrease in performance of BACHD/dnSNARE mice in the light-dark box paradigm. Thus, reduction of astrocytic SNARE-dependent exocytosis has differential effects on the psychiatric-like and motor phenotypes observed in BACHD mice. These data suggest broadly targeting SNARE-dependent exocytosis in astrocytes throughout the brain as a means to modulate gliotransmission in HD may contribute to worsening of specific behavioral deficits and perhaps a brain-region specific approach would be required.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease
    Benn, CL
    Landles, C
    Li, H
    Strand, AD
    Woodman, B
    Sathasivam, K
    Li, SH
    Ghazi-Noori, S
    Hockly, E
    Faruque, SMNN
    Cha, JHJ
    Sharpe, PT
    Olson, JM
    Li, XJ
    Bates, GP
    HUMAN MOLECULAR GENETICS, 2005, 14 (20) : 3065 - 3078
  • [22] Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
    Chen, Xi
    Wu, Jun
    Lvovskaya, Svetlana
    Herndon, Emily
    Supnet, Charlene
    Bezprozvanny, Ilya
    MOLECULAR NEURODEGENERATION, 2011, 6
  • [23] Brain pericyte response in a mouse model of Huntington's disease
    Padel, T.
    Ozen, I.
    Roth, M.
    Paul, G.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 479 - 479
  • [24] Progressive neuronal atrophy in a mouse model of Huntington's disease
    Raza, A. S.
    Davies, S. W.
    JOURNAL OF ANATOMY, 2007, 210 (05) : 607 - 607
  • [25] Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
    Turmaine, M
    Raza, A
    Mahal, A
    Mangiarini, L
    Bates, GP
    Davies, SW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) : 8093 - 8097
  • [26] Studies of a knock-in mouse model of Huntington's disease
    Hickey, MA
    Thomasian, SE
    Gruen, E
    Zeitlin, S
    Li, XJ
    Faull, KF
    Levine, MS
    Chesselet, MF
    MOVEMENT DISORDERS, 2003, 18 (09) : 1091 - 1091
  • [27] Behavioural assessment of a mouse genetic model of Huntington's disease
    Johnston, HM
    Ennis, M
    Myers, RM
    Shelbourne, PF
    BRAIN RESEARCH, 1998, 809 (01) : A26 - A26
  • [28] Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease
    Schroeder, Analyne M.
    Bin Wang, Huei
    Park, Saemi
    Jordan, Maria C.
    Gao, Fuying
    Coppola, Giovanni
    Fishbein, Michael C.
    Roos, Kenneth P.
    Ghiani, Cristina A.
    Colwell, Christopher S.
    PLOS ONE, 2016, 11 (01):
  • [29] Imaging brain metabolism in a mouse model of Huntington's disease
    Farzana, Farheen
    McConville, Malcolm
    Hannan, Anthony
    Hatters, Danny
    Boughton, Berin
    PROTEIN SCIENCE, 2021, 30 : 27 - 27
  • [30] Altered dopaminergic function in a mouse model of Huntington's disease
    Dallérac, GM
    Milner, AJ
    Cummings, DM
    Vatsavayai, SC
    Hirst, MC
    Murphy, KPSJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76